C-MYC Aberrations as Prognostic Factors in Diffuse Large B-cell Lymphoma: A Meta-Analysis of Epidemiological Studies | PLOS ONE
Diffuse Large B-Cell Lymphoma: An Overview | MyLymphomaTeam
Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
Diffuse Large B-Cell Lymphoma | NEJM
Limited-stage diffuse large B-cell lymphoma - ScienceDirect
Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/6-Figure3-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Interim PET in Diffuse Large B-Cell Lymphoma | Journal of Nuclear Medicine
CHN1 is prognostic marker for diffuse large B-cell lymphoma | PGPM
Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes? - Morin - 2022 - British Journal of Haematology - Wiley Online Library
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces - eBioMedicine
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
PDF) Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis | Ismail Matalka - Academia.edu
More accurate prognostic prediction in diffuse large B-cell lymphoma: beyond cell-of-origin - Annals of Oncology
Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma
Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Non-Hodgkin lymphoma - Clinical
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/3-Figure1-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")
PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar
Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
![PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7ef8b2d6bb8eef5420a757ef68eb53fcce0f81e5/5-Figure2-1.png "PDF] Biological prognostic markers in diffuse large B-cell lymphoma. | Semantic Scholar")